Results 201 to 210 of about 53,092 (237)
Some of the next articles are maybe not open access.
Non-alcoholic Steatohepatitis and Cancer
Clinics in Liver Disease, 2007Hepatocellular carcinoma (HCC) is part of the natural history of non-alcoholic steatohepatitis (NASH). A significant proportion of people who have cryptogenic cirrhosis develop HCC. NASH-related cirrhosis carries a substantial risk for early HCC development.
openaire +2 more sources
Non‐alcoholic steatohepatitis in children
Pediatric Transplantation, 2004Abstract: Obesity has emerged as a significant new health problem in the pediatric population. Non‐alcoholic steatohepatitis (NASH) is an entity in the spectrum of non‐alcoholic fatty liver disease (NAFLD) ranges from fat in the liver – simple steatosis, NASH/ steatohepatitis – fat with inflammation and/or fibrosis to advanced fibrosis and cirrhosis ...
openaire +2 more sources
Current Diagnostic Pathology, 1998
Non-alcoholic steatohepatitis (NASH) has become recognized as a relatively common cause of abnormal liver function tests. It is defined by a combination of clinical features (excluding excess alcohol intake) and histopathological biopsy features which are indistinguishable from those of alcoholic hepatitis.
openaire +3 more sources
Non-alcoholic steatohepatitis (NASH) has become recognized as a relatively common cause of abnormal liver function tests. It is defined by a combination of clinical features (excluding excess alcohol intake) and histopathological biopsy features which are indistinguishable from those of alcoholic hepatitis.
openaire +3 more sources
Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis
Scandinavian Journal of Gastroenterology, 2001Non-alcoholic steatohepatitis (NASH) is a form of liver disease resembling alcoholic liver disease in a patient who does not consume significant amounts of alcohol. Since its first description in 1980 it has been recognized with increasing frequency. The natural course is relatively benign, but liver cirrhosis.
openaire +3 more sources
[Non-alcoholic steatohepatitis].
Medicina clinica, 2003Nonalcoholic steatohepatitis (NASH) is a condition characterized histologically by macrovesicular steatosis and lobular hepatitis with necrosis or ballooning degeneration and/or fibrosis--a picture resembling alcoholic hepatitis, in the absence of alcohol abuse. Most patients with NASH are asymptomatic, and the disease is detected incidentally.
Juan, Caballería, Juan, Rodés
+6 more sources
Liraglutide for patients with non-alcoholic steatohepatitis
The Lancet, 2016The Article by Matthew Armstrong and colleagues (Feb 13, p 679) reports different outcomes to those initially registered in the trial protocol.
Dale, A, Hartley, P, Heneghan, C
openaire +3 more sources
Efruxifermin in non-alcoholic steatohepatitis
The Lancet Gastroenterology & Hepatology, 2023Sara, Mahgoub, Philip N, Newsome
openaire +2 more sources
Non-alcoholic steatohepatitis.
The Journal of the Association of Physicians of India, 2005Non-alcoholic steatohepatitis (NASH) represents only a part of a wide spectrum of non-alcoholic fatty liver disease (NAFLD) and its prevalence is only 2 - 3% in the general population. Obesity, diabetes, hyperlipidemia and female sex are important risk factors for NASH.
K, Das, P, Kar
openaire +1 more source
Statins and non-alcoholic steatohepatitis
Metabolism, 2017Vasilios G, Athyros +2 more
openaire +2 more sources